Milestone Scientific Statistics
Share Statistics
Milestone Scientific has 78.48M
shares outstanding. The number of shares has increased by 0.86%
in one year.
| Shares Outstanding | 78.48M |
| Shares Change (YoY) | 0.86% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 5.55% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 174 |
| FTD / Avg. Volume | 0.22% |
Short Selling Information
The latest short interest is 94.5K, so 0.12% of the outstanding
shares have been sold short.
| Short Interest | 94.5K |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.15% |
| Short Ratio (days to cover) | 2.88 |
Valuation Ratios
The PE ratio is -16.25 and the forward
PE ratio is -33.67.
Milestone Scientific's PEG ratio is
0.44.
| PE Ratio | -16.25 |
| Forward PE | -33.67 |
| PS Ratio | 8.88 |
| Forward PS | 5.9 |
| PB Ratio | 13.13 |
| P/FCF Ratio | -26.14 |
| PEG Ratio | 0.44 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Milestone Scientific.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48,
with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.48 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | -0.05 |
| Debt / FCF | -0.12 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $507,642.82 |
| Profits Per Employee | $-277,270.41 |
| Employee Count | 17 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 0.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 28.6% in the
last 52 weeks. The beta is 0.93, so Milestone Scientific's
price volatility has been higher than the market average.
| Beta | 0.93 |
| 52-Week Price Change | 28.6% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 0.96 |
| Relative Strength Index (RSI) | 50.43 |
| Average Volume (20 Days) | 78,037 |
Income Statement
In the last 12 months, Milestone Scientific had revenue of 8.63M
and earned -4.71M
in profits. Earnings per share was -0.06.
| Revenue | 8.63M |
| Gross Profit | 6.43M |
| Operating Income | -6.76M |
| Net Income | -4.71M |
| EBITDA | -6.72M |
| EBIT | -6.76M |
| Earnings Per Share (EPS) | -0.06 |
Full Income StatementBalance Sheet
The company has 3.26M in cash and 349.05K in
debt, giving a net cash position of 2.91M.
| Cash & Cash Equivalents | 3.26M |
| Total Debt | 349.05K |
| Net Cash | 2.91M |
| Retained Earnings | -128.05M |
| Total Assets | 9.09M |
| Working Capital | 4.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -2.92M
and capital expenditures -10.13K, giving a free cash flow of -2.93M.
| Operating Cash Flow | -2.92M |
| Capital Expenditures | -10.13K |
| Free Cash Flow | -2.93M |
| FCF Per Share | -0.04 |
Full Cash Flow StatementMargins
Gross margin is 74.56%, with operating and profit margins of -78.3% and -54.62%.
| Gross Margin | 74.56% |
| Operating Margin | -78.3% |
| Pretax Margin | -54.62% |
| Profit Margin | -54.62% |
| EBITDA Margin | -77.86% |
| EBIT Margin | -78.3% |
| FCF Margin | -33.95% |
